Results of treatment with gefitinib ("Iressa",ZD1839) in 45 patients with advanced non-small-cell lung cancer

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F03%3A00008833" target="_blank" >RIV/00216224:14110/03:00008833 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Results of treatment with gefitinib ("Iressa",ZD1839) in 45 patients with advanced non-small-cell lung cancer

Original language description

Forty-five patients with non-small-cell lung cancer underwent treatment with gefitinib; 51% of them had prior radiotherapy. Treatment duration was 1 to 14 months (median, 3 months). Diseased progressed in 18 patients within 3 months, but stabilised in 27patients for longer than 3 months. Disease-related symptoms were generally milder after gefitinib treatment.

Czech name

—

Czech description

—

Type

D - Article in proceedings

CEP classification

FC - Pneumology

OECD FORD branch

—

Project

—

Continuities

Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

2003

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Article name in the collection

Woorkbook of Iressa Clinical Experience Meeting

ISBN

—

ISSN

—

e-ISSN

—

Number of pages

1

Pages from-to

58

Publisher name

AstraZeneca

Place of publication

Madrid, Spain

Event location

Madrid

Event date

Jun 28, 2003

Type of event by nationality

WRD - Celosvětová akce

UT code for WoS article

—